Capacitative Ca2+ Entry in Pulmonary Myocyte Growth
肺肌细胞生长中的电容性 Ca2+ 进入
基本信息
- 批准号:6983364
- 负责人:
- 金额:$ 33.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-12-05 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Pulmonary vasoconstriction and vascular
smooth muscle proliferation greatly contribute to the elevated pulmonary
vascular resistance and arterial pressure in patients with primary pulmonary
hypertension (PPH), a fatal disease with unknown causes. A common theory is
that vasoconstriction and cell proliferation use overlapping signaling
processes that result in parallel intracellular events. A rise in cytosolic
Ca2+ ([Ca2+]cyt) stimulates cell contraction and proliferation. Thus,
intracellular Ca2+ may serve as a shared signal transduction element that leads
to pulmonary vasoconstriction and vascular remodeling in PPH. [Ca2+]cyt about
pulmonary artery smooth muscle cells (PASMC) is increased by Ca2+ release from
the sarcoplasmic reticulum (SR) and Ca2+ influx through sarcolemmal
Ca2+-permeable channels. The mitogen-induced changes in [Ca2+]cyt consist of an
initial release of Ca2+ from the SR followed by a sustained Ca2+ influx.
Depletion of the SR Ca2+ induces capacitative Ca2+ entry (CCE), which maintains
the sustained Ca2+ influx and refills Ca2+ into the SR. The TRP-encoded
proteins may form the Ca2+-permeable channels that are responsible for CCE. In
human PASMC, the mRNA and protein levels of TRP1 were significantly higher in
proliferating cells than in growth-arrested cells. The enhanced TRP1 mRNA and
protein expression was associated with increases in [Ca2+]cyt due to Ca2+
release from the SR and CCE. These results imply that the up-regulation o TRP1
may contribute to the increased CCE, and elevated [Ca2+]cyt and
intracellularly-stored [Ca2+] in the SR ([Ca2+]SR). Based on these data, we
hypothesize that up-regulation of TRP genes leads to an increase in the
activity of a TRP-encoded Ca2+ channel. This channel would then serve as a
critical Ca2+ entry pathway to raise [Ca2+]cyt and refill Ca2+ into the SR,
both of which are necessary for pulmonary vasoconstriction and PASMC
proliferation. The up-regulated TRP genes, augmented Ca2+ release-activated
(store depletion-mediated) Ca2+ currents (ICRAC), and enhanced CCE may thus
play a critical role in the elevated pulmonary vascular resistance in PPH
patients. Three Specific Aims are addressed to test the hypotheses: 1) to
characterize the TRP gene expression, ICRAC, CCE, and [Ca2+]SR in normal human
PASMC, and to compare these parameters between growth-arrested and
proliferating cells; 2) to investigate whether functional expression of TRPs
facilitates cell proliferation by increasing resting [Ca2+]cyt, CCE, and
[Ca2+]SR in normal human PASMC; and 3) to investigate and compare ICRAC,
molecular expression of TRP channels, spatial and temporal changes of [Ca2+]cyt
through CCE, and [Ca2+]SR in PASMC from normal subjects and patients with
non-pulmonary hypertension diseases, secondary pulmonary hypertension, and PPH.
描述(由申请人提供):肺血管收缩和血管
平滑肌增生在很大程度上有助于肺动脉高压
原发性肺动脉高压患者的血管阻力和动脉压
高血压(PPH),一种原因不明的致命疾病。一个普遍的理论是
血管收缩和细胞增殖使用重叠信号
导致平行细胞内事件的过程。细胞质中
Ca 2+([Ca 2 +]cyt)刺激细胞收缩和增殖。因此,在本发明中,
细胞内Ca 2+可能作为一个共享的信号转导元件,
PPH时肺血管收缩和血管重构。[Ca2+]cyt关于
肺动脉平滑肌细胞(PASMC)的钙释放增加,
肌浆网(SR)和Ca ~(2+)通过肌膜内流
Ca 2+渗透通道。丝裂原诱导的[Ca 2 +]cyt的变化包括:
从SR中初始释放Ca 2+,随后持续的Ca 2+内流。
SR Ca 2+的耗尽诱导电容性Ca 2+内流(CCE),其维持
持续的Ca 2+内流并将Ca 2+重新填充到SR中。TRP编码的
蛋白质可以形成负责CCE的Ca 2+渗透通道。在
在人PASMC中,TRP 1的mRNA和蛋白水平显著高于人PASMC,
增殖的细胞比生长停滞的细胞。增强的TRP 1 mRNA和
蛋白表达与[Ca 2 +]cyt增加相关,
从SR和CCE释放。这些结果表明,TRP 1的上调可能与TRP 1的表达有关。
可能导致CCE增加,[Ca 2 +]cyt升高,
细胞内储存的[Ca 2 +]在SR([Ca 2 +]SR)中。根据这些数据,我们
假设TRP基因的上调导致了
TRP编码的Ca 2+通道的活性。该通道将作为
关键的Ca 2+进入途径,以提高[Ca 2 +]cyt并将Ca 2+重新填充到SR中,
这两者对于肺血管收缩和PASMC都是必需的
增殖上调的TRP基因,增强了Ca 2+释放激活的
(钙库耗竭介导的)Ca 2+电流(ICRAC),因此增强的CCE可能
在PPH中肺血管阻力升高中起关键作用
患者三个具体目标是解决测试的假设:1)
分析正常人TRP基因表达、ICRAC、CCE和[Ca 2 +]SR
PASMC,并比较这些参数之间的生长停滞和
增殖细胞; 2)研究TRP的功能表达是否
通过增加静息[Ca 2 +]cyt、CCE和
[Ca2+]正常人PASMC中的SR;和3)研究和比较ICRAC,
TRP通道的分子表达,[Ca 2 +]cyt的时空变化
正常人和肺心病患者PASMC内[Ca ~(2+)]SR
非肺动脉高压疾病、继发性肺动脉高压和PPH。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason X J Yuan其他文献
Jason X J Yuan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason X J Yuan', 18)}}的其他基金
Pre-Clinical Models of VILI /ARDS Core
VILI /ARDS Core 的临床前模型
- 批准号:
10094244 - 财政年份:2018
- 资助金额:
$ 33.4万 - 项目类别:
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
肺动脉高压中的离子通道和膜受体
- 批准号:
10334539 - 财政年份:2017
- 资助金额:
$ 33.4万 - 项目类别:
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
肺动脉高压中的离子通道和膜受体
- 批准号:
10163893 - 财政年份:2017
- 资助金额:
$ 33.4万 - 项目类别:
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
肺动脉高压中的离子通道和膜受体
- 批准号:
9927824 - 财政年份:2017
- 资助金额:
$ 33.4万 - 项目类别:
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
肺动脉高压中的离子通道和膜受体
- 批准号:
9457280 - 财政年份:2017
- 资助金额:
$ 33.4万 - 项目类别:
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
肺动脉高压中的离子通道和膜受体
- 批准号:
10563148 - 财政年份:2017
- 资助金额:
$ 33.4万 - 项目类别:
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
肺动脉高压中的离子通道和膜受体
- 批准号:
10022708 - 财政年份:2017
- 资助金额:
$ 33.4万 - 项目类别:
Molecular mechanisms of downregulated Kv channels in IPAH: Role of microRNA
IPAH 中 Kv 通道下调的分子机制:microRNA 的作用
- 批准号:
8534280 - 财政年份:2012
- 资助金额:
$ 33.4万 - 项目类别:
Molecular mechanisms of downregulated Kv channels in IPAH: Role of microRNA
IPAH 中 Kv 通道下调的分子机制:microRNA 的作用
- 批准号:
9066768 - 财政年份:2012
- 资助金额:
$ 33.4万 - 项目类别:
Molecular mechanisms of downregulated Kv channels in IPAH: Role of microRNA
IPAH 中 Kv 通道下调的分子机制:microRNA 的作用
- 批准号:
8895028 - 财政年份:2012
- 资助金额:
$ 33.4万 - 项目类别:
相似海外基金
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
- 批准号:
10322143 - 财政年份:2021
- 资助金额:
$ 33.4万 - 项目类别:
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
- 批准号:
10154169 - 财政年份:2021
- 资助金额:
$ 33.4万 - 项目类别:
Control of calcium flux and mitochondrial fission by the Charcot Marie Tooth disease protein Mfn2.
腓骨肌萎缩症蛋白 Mfn2 对钙通量和线粒体裂变的控制。
- 批准号:
10540812 - 财政年份:2021
- 资助金额:
$ 33.4万 - 项目类别:
Boron accelerates cultured osteoblastic cell activity through calcium flux
硼通过钙流加速培养的成骨细胞活性
- 批准号:
25670812 - 财政年份:2013
- 资助金额:
$ 33.4万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Claudin 12 mediates paracellular calcium flux between opossum kidney cell monolayers
Claudin 12 介导负鼠肾细胞单层之间的细胞旁钙通量
- 批准号:
240882 - 财政年份:2011
- 资助金额:
$ 33.4万 - 项目类别:
Molecules & Mechanisms Mediating Proximal Tubular Calcium Flux
分子
- 批准号:
244633 - 财政年份:2011
- 资助金额:
$ 33.4万 - 项目类别:
Salary Programs
Mercury induced disruptions of cellular calcium flux in paired neurons from lymnaea affect synaptic transmission and elicit apoptosis
汞诱导的成对神经元中细胞钙通量的破坏影响突触传递并引发细胞凋亡
- 批准号:
348881-2007 - 财政年份:2007
- 资助金额:
$ 33.4万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's














{{item.name}}会员




